HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-MAY-16 5K7I TITLE IRAK4 IN COMPLEX WITH AZ3864 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 160-460; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, KINASE, PROTEIN TYROSINE KINASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 3 27-SEP-23 5K7I 1 REMARK REVDAT 2 10-JAN-18 5K7I 1 JRNL REVDAT 1 06-DEC-17 5K7I 0 JRNL AUTH J.S.SCOTT,S.L.DEGORCE,R.ANJUM,J.CULSHAW,R.D.M.DAVIES, JRNL AUTH 2 N.L.DAVIES,K.S.DILLMAN,J.E.DOWLING,L.DREW,A.D.FERGUSON, JRNL AUTH 3 S.D.GROOMBRIDGE,C.T.HALSALL,J.A.HUDSON,S.LAMONT,N.A.LINDSAY, JRNL AUTH 4 S.K.MARDEN,M.F.MAYO,J.E.PEASE,D.R.PERKINS,J.H.PINK,G.R.ROBB, JRNL AUTH 5 A.ROSEN,M.SHEN,C.MCWHIRTER,D.WU JRNL TITL DISCOVERY AND OPTIMIZATION OF PYRROLOPYRIMIDINE INHIBITORS JRNL TITL 2 OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE 4 (IRAK4) FOR JRNL TITL 3 THE TREATMENT OF MUTANT MYD88L265P DIFFUSE LARGE B-CELL JRNL TITL 4 LYMPHOMA. JRNL REF J. MED. CHEM. V. 60 10071 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29172502 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01290 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 71.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 30401 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1491 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2972 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2839 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE : 0.2480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 133 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4349 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 85.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.34750 REMARK 3 B22 (A**2) : -11.44710 REMARK 3 B33 (A**2) : 10.09960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.380 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.300 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.225 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.304 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.228 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4500 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6073 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1633 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 127 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 622 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4500 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 580 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5078 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.78 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.28 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -16.7511 -30.6548 -16.7598 REMARK 3 T TENSOR REMARK 3 T11: -0.0286 T22: -0.2925 REMARK 3 T33: -0.4988 T12: 0.2430 REMARK 3 T13: 0.0213 T23: 0.0190 REMARK 3 L TENSOR REMARK 3 L11: 2.4013 L22: 1.5185 REMARK 3 L33: 6.8650 L12: -0.6005 REMARK 3 L13: -1.9106 L23: 0.4849 REMARK 3 S TENSOR REMARK 3 S11: -0.2656 S12: -0.1754 S13: -0.1884 REMARK 3 S21: 0.1423 S22: 0.1340 S23: -0.1978 REMARK 3 S31: 1.1597 S32: 0.8678 S33: 0.1316 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -56.3771 -24.6290 -15.0739 REMARK 3 T TENSOR REMARK 3 T11: 0.1615 T22: -0.2295 REMARK 3 T33: -0.3355 T12: -0.0729 REMARK 3 T13: 0.0166 T23: -0.0383 REMARK 3 L TENSOR REMARK 3 L11: 3.6055 L22: 1.7543 REMARK 3 L33: 7.0919 L12: -1.0205 REMARK 3 L13: -2.4556 L23: 0.8766 REMARK 3 S TENSOR REMARK 3 S11: 0.6294 S12: 0.2709 S13: 0.0622 REMARK 3 S21: -0.1191 S22: -0.2529 S23: 0.1692 REMARK 3 S31: -0.3254 S32: -0.4636 S33: -0.3765 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5K7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000221857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8-7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.10406 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 74.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : 8.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2NRU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M AMMONIUM SULFATE, 0.1 M HEPES, REMARK 280 PH 7.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.77000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.26500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 71.21000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.77000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.26500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 71.21000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.77000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.26500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 71.21000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.77000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.26500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 71.21000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 ILE A 221 REMARK 465 THR A 222 REMARK 465 THR A 223 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 SER A 253 REMARK 465 ASP A 254 REMARK 465 GLY A 255 REMARK 465 ASP A 256 REMARK 465 SER A 336 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 THR A 342 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 GLY B 195 REMARK 465 GLY B 196 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 SER B 253 REMARK 465 ASP B 254 REMARK 465 GLY B 255 REMARK 465 ASP B 256 REMARK 465 ASP B 257 REMARK 465 LEU B 258 REMARK 465 SER B 336 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 THR B 342 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 181 96.58 -55.79 REMARK 500 GLU A 182 0.46 -66.03 REMARK 500 ASN A 207 -7.47 67.16 REMARK 500 ARG A 310 -8.67 78.53 REMARK 500 ASP A 311 54.48 -143.00 REMARK 500 ASP A 329 86.00 61.52 REMARK 500 ARG A 347 79.95 -110.10 REMARK 500 LYS A 417 34.36 -89.25 REMARK 500 GLU B 172 -54.16 148.87 REMARK 500 ASN B 207 -4.46 70.98 REMARK 500 ARG B 310 -7.61 78.29 REMARK 500 ASP B 311 53.69 -144.16 REMARK 500 ASP B 329 86.03 61.80 REMARK 500 ARG B 347 79.12 -109.44 REMARK 500 LYS B 417 34.68 -89.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6QZ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6QZ B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5K72 RELATED DB: PDB REMARK 900 RELATED ID: 5K75 RELATED DB: PDB REMARK 900 RELATED ID: 5K76 RELATED DB: PDB REMARK 900 RELATED ID: 5K7G RELATED DB: PDB DBREF 5K7I A 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 DBREF 5K7I B 160 460 UNP Q9NWZ3 IRAK4_HUMAN 160 460 SEQRES 1 A 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 A 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 A 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 A 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 A 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 A 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 A 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 A 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 A 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 A 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 A 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 A 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 A 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 A 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 A 301 THR VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 A 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 A 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 A 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 A 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 A 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 A 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 A 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 A 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 A 301 ALA SER SEQRES 1 B 301 VAL SER ASP THR ARG PHE HIS SER PHE SER PHE TYR GLU SEQRES 2 B 301 LEU LYS ASN VAL THR ASN ASN PHE ASP GLU ARG PRO ILE SEQRES 3 B 301 SER VAL GLY GLY ASN LYS MET GLY GLU GLY GLY PHE GLY SEQRES 4 B 301 VAL VAL TYR LYS GLY TYR VAL ASN ASN THR THR VAL ALA SEQRES 5 B 301 VAL LYS LYS LEU ALA ALA MET VAL ASP ILE THR THR GLU SEQRES 6 B 301 GLU LEU LYS GLN GLN PHE ASP GLN GLU ILE LYS VAL MET SEQRES 7 B 301 ALA LYS CYS GLN HIS GLU ASN LEU VAL GLU LEU LEU GLY SEQRES 8 B 301 PHE SER SER ASP GLY ASP ASP LEU CYS LEU VAL TYR VAL SEQRES 9 B 301 TYR MET PRO ASN GLY SER LEU LEU ASP ARG LEU SER CYS SEQRES 10 B 301 LEU ASP GLY THR PRO PRO LEU SER TRP HIS MET ARG CYS SEQRES 11 B 301 LYS ILE ALA GLN GLY ALA ALA ASN GLY ILE ASN PHE LEU SEQRES 12 B 301 HIS GLU ASN HIS HIS ILE HIS ARG ASP ILE LYS SER ALA SEQRES 13 B 301 ASN ILE LEU LEU ASP GLU ALA PHE THR ALA LYS ILE SER SEQRES 14 B 301 ASP PHE GLY LEU ALA ARG ALA SER GLU LYS PHE ALA GLN SEQRES 15 B 301 THR VAL MET TPO SEP ARG ILE VAL GLY THR THR ALA TYR SEQRES 16 B 301 MET ALA PRO GLU ALA LEU ARG GLY GLU ILE THR PRO LYS SEQRES 17 B 301 SER ASP ILE TYR SER PHE GLY VAL VAL LEU LEU GLU ILE SEQRES 18 B 301 ILE THR GLY LEU PRO ALA VAL ASP GLU HIS ARG GLU PRO SEQRES 19 B 301 GLN LEU LEU LEU ASP ILE LYS GLU GLU ILE GLU ASP GLU SEQRES 20 B 301 GLU LYS THR ILE GLU ASP TYR ILE ASP LYS LYS MET ASN SEQRES 21 B 301 ASP ALA ASP SER THR SER VAL GLU ALA MET TYR SER VAL SEQRES 22 B 301 ALA SER GLN CYS LEU HIS GLU LYS LYS ASN LYS ARG PRO SEQRES 23 B 301 ASP ILE LYS LYS VAL GLN GLN LEU LEU GLN GLU MET THR SEQRES 24 B 301 ALA SER MODRES 5K7I TPO A 345 THR MODIFIED RESIDUE MODRES 5K7I SEP A 346 SER MODIFIED RESIDUE MODRES 5K7I TPO B 345 THR MODIFIED RESIDUE MODRES 5K7I SEP B 346 SER MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 10 HET TPO B 345 11 HET SEP B 346 10 HET 6QZ A 501 33 HET SO4 B 501 5 HET 6QZ B 502 33 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 6QZ (3~{A}~{R},7~{A}~{S})-1-METHYL-5-[4-[[5-(OXAN-4-YL)- HETNAM 2 6QZ 7~{H}-PYRROLO[2,3-D]PYRIMIDIN-4-YL]AMINO]CYCLOHEXYL]- HETNAM 3 6QZ 3,3~{A},4,6,7,7~{A}-HEXAHYDROPYRROLO[3,2-C]PYRIDIN-2- HETNAM 4 6QZ ONE HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 6QZ 2(C25 H36 N6 O2) FORMUL 4 SO4 O4 S 2- FORMUL 6 HOH *77(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 LYS A 227 CYS A 240 1 14 HELIX 3 AA3 SER A 269 SER A 275 1 7 HELIX 4 AA4 CYS A 276 THR A 280 5 5 HELIX 5 AA5 SER A 284 ASN A 305 1 22 HELIX 6 AA6 LYS A 313 ALA A 315 5 3 HELIX 7 AA7 THR A 351 MET A 355 5 5 HELIX 8 AA8 ALA A 356 ARG A 361 1 6 HELIX 9 AA9 THR A 365 GLY A 383 1 19 HELIX 10 AB1 LEU A 395 LEU A 397 5 3 HELIX 11 AB2 ASP A 398 ASP A 405 1 8 HELIX 12 AB3 THR A 409 ILE A 414 1 6 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 THR A 458 1 13 HELIX 16 AB7 GLU B 224 CYS B 240 1 17 HELIX 17 AB8 SER B 269 SER B 275 1 7 HELIX 18 AB9 CYS B 276 THR B 280 5 5 HELIX 19 AC1 SER B 284 ASN B 305 1 22 HELIX 20 AC2 LYS B 313 ALA B 315 5 3 HELIX 21 AC3 ALA B 356 ARG B 361 1 6 HELIX 22 AC4 THR B 365 GLY B 383 1 19 HELIX 23 AC5 LEU B 395 LEU B 397 5 3 HELIX 24 AC6 ASP B 398 ASP B 405 1 8 HELIX 25 AC7 ASP B 422 LEU B 437 1 16 HELIX 26 AC8 LYS B 440 ARG B 444 5 5 HELIX 27 AC9 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O LEU A 249 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LYS A 214 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 VAL A 199 VAL A 205 -1 N VAL A 205 O THR A 208 SHEET 6 AA1 6 LYS A 191 GLU A 194 -1 N GLY A 193 O VAL A 200 SHEET 1 AA2 2 ILE A 317 LEU A 319 0 SHEET 2 AA2 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA3 6 HIS B 166 SER B 167 0 SHEET 2 AA3 6 LEU B 248 PHE B 251 1 O LEU B 249 N HIS B 166 SHEET 3 AA3 6 LEU B 260 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA3 6 THR B 208 LYS B 214 -1 N LYS B 213 O LEU B 260 SHEET 5 AA3 6 VAL B 199 VAL B 205 -1 N VAL B 205 O THR B 208 SHEET 6 AA3 6 LYS B 191 GLY B 193 -1 N GLY B 193 O VAL B 200 SHEET 1 AA4 2 ILE B 317 LEU B 319 0 SHEET 2 AA4 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C MET A 344 N TPO A 345 1555 1555 1.35 LINK C TPO A 345 N SEP A 346 1555 1555 1.34 LINK C SEP A 346 N ARG A 347 1555 1555 1.36 LINK C MET B 344 N TPO B 345 1555 1555 1.35 LINK C TPO B 345 N SEP B 346 1555 1555 1.34 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLU A 392 PRO A 393 0 0.38 CISPEP 2 GLU B 392 PRO B 393 0 -0.16 SITE 1 AC1 13 MET A 192 GLY A 193 GLU A 194 ALA A 211 SITE 2 AC1 13 LYS A 213 VAL A 246 TYR A 262 VAL A 263 SITE 3 AC1 13 TYR A 264 MET A 265 ASP A 272 LEU A 318 SITE 4 AC1 13 HOH A 609 SITE 1 AC2 2 SER A 423 ASN B 207 SITE 1 AC3 12 MET B 192 GLY B 193 GLU B 194 ALA B 211 SITE 2 AC3 12 LYS B 213 TYR B 262 VAL B 263 MET B 265 SITE 3 AC3 12 ASP B 272 LEU B 318 HOH B 603 HOH B 628 CRYST1 87.540 110.530 142.420 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011423 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009047 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007021 0.00000